24. Schrag A, Hovris A, Morley D, Quinn N, Jahanshahi M. Caregiverburden in Parkinson’s disease is closely associated with psychiatric symptoms, falls, and disability. Parkinsonism & Related Disorders. 2006;12(1):35–41.
25. Schulz R, Beach SR. Caregiving as a risk factor for mortality: the caregiver health effects study. JAMA. 1999;282(23):2215–2219.
26. Ahlskog JE. Beating a dead horse: dopamine and Parkinson disease. Neurology. 2007;69(17):1701–1711.
27. Nijkrake MJ, Keus SHJ, Overeem S, et al. The ParkinsonNet concept: development, implementation and initial experience. Movement Disorders. 2010;25(7):823–829; Bloem BR, Rompen L, de Vries NM, Klink A, Munneke M, Jeurissen P. ParkinsonNet: A low-cost health care innovation with a systems approach from the Netherlands. Health Affairs. 2017;36:1987–1996; Munneke M, Nijkrake MJ, Keus SHJ, et al. Efficacy of community-based physiotherapy networks for patients with Parkinson’s disease: a cluster– randomised trial. Lancet Neurology. 2010;9(1):46–54; Wensing M, van der Eijk M, Koetsenruijter J, Bloem BR, Munneke M, Faber M. Connectedness of healthcare professionals involved in the treatment of patients with Parkinson’s disease: a social networks study. Implementation Science. 2011;6(1):67; Keus SHJ, Oude Nijhuis LB, Nijkrake MJ, Bloem BR, Munneke M. Improving community healthcare for patients with Parkinson’s disease: the Dutch model. Journal of Parkinsons Disease. 2012;2012:543426; van der Ejik M, Faber MJ, Aarts JW, Kremer JA, Munneke M, Bloem BR. Using online health communities to deliver patientcentered care to people with chronic conditions. Journal of Medical Internet Research. 2013;15(6):e115; Sturkenboom IHWM, Graff MJL, Hendriks JCM, et al. Efficacy of occupational therapy for patients with Parkinson’s disease: a randomised controlled trial. Lancet Neurology. 2014;13(6):557–566; Bloem BR, Munneke M. Revolutionising management of chronic disease: the ParkinsonNet approach. BMJ. 2014;348:g1838; Ypinga JHL, de Vries NM, Boonen LHHM, et al. Effectiveness and costs of specialised physiotherapy given via ParkinsonNet: a retrospective analysis of medical claims data. Lancet Neurology. 2018;17(2):153–161.
28. Bloem BR, Rompen L, de Vries NM, Klink A, Munneke M, Jeurissen P. ParkinsonNet: a low-cost health care innovation with a systems approach from the Netherlands. Health Affairs. 2017;36:1987–1996.
29. Там же.
30. Dorsey ER, Glidden AM, Holloway MR, Birbeck GL, Schwamm LH. Teleneurology and mobile technologies: the future of neurological care. Nature Reviews Neurology. 2018;14:285–297.
31. Arora S, Thornton K, Murata G, et al. Outcomes of Treatment for Hepatitis C Virus Infection by Primary Care Providers. New England Journal of Medicine. 2011;364(23):2199–2207.
32. Arora S. Project ECHO: the evidence is catching up with the enthusiasm. Health Affairs Blog. January 13, 2017. www.healthaffairs.org/do/10.1377/ hblog20170113.058331/full. Accessed June 27, 2019; Catic AG, Mattison MLP, Bakaev I, Morgan M, Monti SM, Lipsitz L. ECHOAGE: an innovative model of geriatric care for long-term care residents with dementia and behavioral issues. Journal of the American Medical Directors Association. 2014;15(12):938–942; Project ECHO: a revolution in medical education and care delivery. University of New Mexico. https://echo.unm.edu. Accessed November 11, 2018.
33. Dorsey ER, Glidden AM, Holloway MR, Birbeck GL, Schwamm LH. Teleneurology and mobile technologies: the future of neurological care. Nature Reviews Neurology. 2018;14:285–297.
34. Meyer GS, Gibbons RV. House calls to the elderly – a vanishing practice among physicians. New England Journal of Medicine. 1997;337(25):1815–1820.
35. Там же.
36. Sairenji T, Jetty A, Peterson LE. Shifting patterns of physician home visits. Journal of Primary Care & Community Health. 2015;7(2):71–75.
37. Fleisher J, Barbosa W, Sweeney MM, et al. Interdisciplinary home visits for individuals with advanced Parkinson’s disease and related disorders. Journal of the American Geriatrics Society. 2018;66(6):1226–1232.
38. Там же.
39. Hack N, Akbar U, Monari, EH, et al. Person-centered care in the home setting for Parkinson’s disease: operation house call quality of care pilot study. Journal of Parkinsons Disease. 2015;2015;639494. doi:10.1155/2015/639494. www.ncbi.nlm.nih.gov/pmc/articles/ PMC4452493.
40. Beck CA, Beran DB, Biglan KM, et al. National randomized controlled trial of virtual house calls for Parkinson disease. Neurology. 2017;89(11):1152–1161; Shah SP, Glenn GL, Hummel EM, et al. Caregiver tele-support group for Parkinson’s disease: a pilot study. Geriatric Nursing. 2015;36(3):207–211; Korn RE, Shukla AW, Katz M, et al. Virtual visits for Parkinson disease. Neurology: Clinical Practice. 2017;7(4):283–295; Venkataraman V, Donohue SJ, Biglan KM, Wicks P, Dorsey ER. Virtual visits for Parkinson disease. Neurology: Clinical Practice. 2014;4(2):146–152.
41. Beck CA, Beran DB, Biglan KM, et al. National randomized controlled trial of virtual house calls for Parkinson disease. Neurology. 2017;89(11):1152–1161; Dorsey ER, Venkataraman V, Grana MJ, et al. Randomized controlled clinical trial of “virtual house calls” for Parkinson disease. JAMA Neurology. 2013;70(5):565–570; Heikkila VM, Turkka J, Korpelainen J, Kallanranta T, Summala H. Decreased driving ability in people with Parkinson’s disease. Journal of Neurology, Neurosurgery & Psychiatry. 1998;64(3):325–330.
42. Beck CA, Beran DB, Biglan KM, et al. National randomized controlled trial of virtual house calls for Parkinson disease. Neurology. 2017;89(11):1152–1161; Dorsey ER, Venkataraman V, Grana MJ, et al. Randomized controlled clinical trial of “virtual house calls” for Parkinson disease. JAMA Neurology. 2013;70(5):565–570; Heikkilg VM, Turkka J, Korpelainen J, Kallanranta T, Summala H. Decreased driving ability in people with Parkinson’s disease. Journal of Neurology, Neurosurgery & Psychiatry. 1998;64(3):325–330.
43. Beck CA, Beran DB, Biglan KM, et al. National randomized controlled trial of virtual house calls for Parkinson disease. Neurology. 2017;89(11):1152–1161.
44. Hubble JP. Interactive video conferencing and Parkinson’s disease. Kansas Medicine. 1992;93(12):351–352.
45. Там же.
46. Achey M, Aldred JL, Aljehani N, et al. The past, present, and future of telemedicine for Parkinson’s disease. Movement Disorders 2014;29(7):871–883. https://onlinelibrary.wiley.com/ doi/full/10.1002/ mds.25903.
47. Silva de Lima AL, Hahn T, Evers LJW, et al. Feasibility of large-scale deployment of multiple wearable sensors in Parkinson’s disease. PLOS ONE. 2017;12(12):e0189161.
48. Lipsmeier F, Taylor KI, Kilchenmann T, et al. Evaluation of smartphonebased testing to generate exploratory outcome measures in a phase 1 Parkinson’s disease clinical trial. Movement Disorders. 2018;33(8):1287–1297.
49. Dorsey ER, Glidden AM, Holloway MR, et al. Teleneurology and mobile technologies: the future of neurological care. Nat Rev Neurol 2018; 14(5):285–297. www.ncbi.nlm.nih.gov/ pubmed/29623949.
50. Sharma S, Padma MV, Bhardwaj A, Sharma A, Sawal N, Thakur S. Telestroke in resource-poor developing country model. Neurology India. 2016;64(5):934–940; Corley J. Telestroke: India’s solution to a public health-care crisis. Lancet Neurology. 2018;17(2): 115–116.
51. Topol E. The Patient Will See You Now: The Future of Medicine Is in Your Hands. Rpt. ed. Basic Books; 2016.
52. Daschle T, Dorsey ER. The return of the house call. Annals of Internal Medicine. 2015;162(8):587–588.
53. Gornick ME, Warren JL, Eggers PW, et al. Thirty years of Medicare: impact on the covered population. Health Care Financing Review. 1996;18(2):179–237; Life expectancy for Social Security. Social Security Administration. www.ssa.gov/history/lifeexpect.html. Accessed November 10, 2018.
54. Thorpe KE, Ogden LL, Galactionova K. Chronic conditions account for rise in Medicare spending from 1987 to 2006. Health Affairs. 2010;29(4):718–724.
55. AARP. Baby boomer facts and figures. AARP Livable Communities. www.aarp.org/livable-communities/info-2014/livable-communities-facts-and-figures.html. Accessed January 5, 2019.
56. Dieleman JL, Baral R, Birger M, et al. US spending on personal health care and public health, 1996–2013. JAMA. 2016;316(24):2627–2646.
57. Там же.
58. Dorsey ER, George BP, Leff B, Willis AW. The coming crisis: obtaining care for the growing burden of neurodegenerative conditions. Neurology. 2013;80(21):1989–1996.
59. Там же.; Barnett ML, Wilcock A, McWilliams JM, et al. Two-year evaluation of mandatory bundled payments for joint replacement. New England Journal of Medicine. 2019;380(3):252–262; Silverman L, Walters D, Aasen E, Tainter R, Whittington J, Holter R. Chapter 7: the cost of a broken hip. KERA. 2017. http://stories.kera.org/the-broken-hip/the-cost-of-a-broken-hip. Accessed February 11, 2019.
60. Dorsey ER, Vlaanderen FP, Engelen LJ, et al. Moving Parkinson care to the home. Movement Disorders. 2016;31(9):1258–1262.
61. Там же.; Gerlach OHH, Winogrodzka A, Weber WEJ. Clinical problems in the hospitalized Parkinson’s disease patient: systematic review. Movement Disorders. 2011;26(2):197–208; Aminoff MJ, Christine CW, Friedman JH, et al. Management of the hospitalized patient with Parkinson’s disease: current state of the field and need for guidelines. Parkinsonism & Related Disorders. 2011;17(3):139–145.
62. Ypinga JHL, de Vries NM, Boonen LHHM, et al. Effectiveness and costs of specialised physiotherapy given via ParkinsonNet: a retrospective analysis of medical claims data.